OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 44 filers reported holding OMEGA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,536 | -57.1% | 435,133 | +11.8% | 0.00% | – |
| Q2 2023 | $2,179,145 | +548.5% | 389,133 | +598.2% | 0.00% | – |
| Q1 2023 | $336,052 | -42.9% | 55,730 | -45.9% | 0.00% | – |
| Q4 2022 | $588,472 | +173.7% | 103,060 | +159.4% | 0.00% | – |
| Q3 2022 | $215,000 | +79.2% | 39,730 | +25.6% | 0.00% | – |
| Q2 2022 | $120,000 | -91.0% | 31,630 | -85.3% | 0.00% | – |
| Q1 2022 | $1,340,000 | +12.8% | 214,768 | +104.8% | 0.00% | – |
| Q4 2021 | $1,188,000 | -9.1% | 104,868 | +51.3% | 0.00% | – |
| Q3 2021 | $1,307,000 | – | 69,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
| CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
| Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
| HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
| Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
| Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
| Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
| Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |